Health and Wealth: The Investors’ Guide to Antimicrobial Resistance (AMR), A Growing Global Health Crisis 

The MSCI Sustainability Institute, IAAMR, and FAIRR have developed an Investor’s Guide to Antimicrobial Resistance (AMR), highlighting its systemic risk and its impact on sectors like healthcare, pharmaceuticals, and animal agriculture. The guide provides an overview of current research and development pipelines for novel antimicrobials and offers opportunities for strategic investments. It also provides case studies from active investors demonstrating their actions on AMR. The guide aims to provide investors with key questions to consider when adopting an “AMR lens” and offers insights into the current research and funding landscapes.